Loading organizations...
§ Private Profile · Berwyn, PA, USA
Mural Health is a technology company.
Mural Health develops a next-generation clinical trial participant management platform designed to streamline and enhance the experience for individuals engaged in clinical research. The company utilizes technology to simplify various aspects of clinical trial involvement, aiming to improve accessibility and engagement for participants. Its core offering provides tools and solutions that foster more efficient and patient-centric clinical study operations.
The company was founded in 2022 by Sam Whitaker, who previously served as the founder and CEO of Greenphire. Whitaker’s insight stemmed from a recognition of the need for a dedicated platform that prioritizes the participant's journey within clinical trials, aiming to address existing complexities and create a more user-friendly environment for those contributing to medical research.
Mural Health’s platform primarily serves clinical trial participants, indirectly benefiting pharmaceutical companies and contract research organizations (CROs) by optimizing participant management. The company's overarching mission is to improve the lives of clinical trial participants, fostering diverse involvement across global populations to ultimately advance health outcomes worldwide. It envisions a future where clinical research is more inclusive and less burdensome for those who participate.
Mural Health has raised $8.0M across 1 funding round.
Mural Health has raised $8.0M in total across 1 funding round.
Mural Health has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Seed in September 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2023 | $8M Seed | Bessemer Venture Partners | Arkitekt Ventures, Flare Capital Partners, Foresite Capital, Friedom Partners, Meritech Capital Partners, Mohamad Makhzoumi, Torch Capital, Vast Ventures, Correlation Ventures, Operator Partners, Project Mayhem Ventures, Virtue | Announced |
Mural Health is a clinical trials technology company that builds Mural Link, the industry's first participant management platform designed to simplify clinical trial participation.[1][2] It serves trial participants, caregivers, clinical sites, and sponsors by solving key pain points like payments, travel, communication, and feedback, delivering 97% engagement rates, 60% reduced dropouts, and 3.1X-10.1X ROI for sponsors.[1][2] Headquartered in Berwyn, Pennsylvania, with 11-50 employees, the company prioritizes patient-first features such as fee-free payments (via PayPal, Venmo, Zelle, direct deposit, or prepaid debit card), on-demand rideshare booking, in-app chat, and real-time analytics, earning recognition as the “Most Innovative Start-Up” at the 2024 Citeline Awards.[1][3]
Mural Health emerged from the legacy of its founders, who in 2008 invented ClinCard, the first clinical trial participant payment technology, scaling it across 4,000+ trials, 75+ countries, 4M+ participants, and 20M+ payments before its 2016 acquisition.[2][5] By 2021, founder Sam recognized that clinical trial tech had stagnated amid evolving consumer technologies, prompting the team—including CTO Mike Remaker, CPO Laura Remaker, COO Nicole Nackley Kerr, and VP Business Development Paul Diercksen—to launch Mural Link in November 2022 as a comprehensive platform.[2][3][4] Early traction included debuting at the 2022 CNS Summit, with patient advocacy initiatives following to address barriers like financial and transportation hurdles that marginalize participants.[4][5]
Mural Health rides the decentralized and patient-centric clinical trials trend, accelerated by post-pandemic demands for remote-friendly, inclusive research to speed therapies to market amid rising trial costs and dropout rates (often 20-30%).[1][4] Timing aligns with regulatory pushes for diversity (e.g., FDA guidelines) and digital health adoption, where outdated tech fails modern participants expecting app-based convenience like Venmo or Uber.[2][5] Market forces favoring it include a $50B+ global clinical trials industry seeking efficiency, with Mural Link influencing the ecosystem by setting new standards for retention data and equity, enabling sponsors to enroll harder-to-reach groups and improve data quality.[1][4]
Mural Health is poised for expansion with platform enhancements like advanced AI-driven retention predictions and broader integrations, capitalizing on its award-winning momentum to capture share in a fragmented market.[1][2] Trends like AI analytics, global trials, and value-based care will amplify its role, potentially evolving it into a full trial orchestration hub. As the pioneer bridging consumer tech with clinical research, Mural Health exemplifies how targeted innovation makes trials not just viable, but participant-empowering—unlocking faster, fairer paths to life-saving treatments.[1][5]
Mural Health has raised $8.0M in total across 1 funding round.
Mural Health's investors include Bessemer Venture Partners, Arkitekt Ventures, Flare Capital Partners, Foresite Capital, Friedom Partners, Meritech Capital Partners, Mohamad Makhzoumi, Torch Capital, Vast Ventures, Correlation Ventures, Operator Partners, Project Mayhem Ventures.